Clinical Trials Logo

Clinical Trial Summary

This study aims to study, in patient with Parkinson's disease, mild to moderate stage (according to Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease, Postuma et al., 2015): - the evolution of oculomotricity markers over time. - the correlation between neurological evaluations (motor and non-motor scores), neuropsychological evaluations (cognitive disorders) and oculomotricity evaluation, over a follow-up period of 7 years. - the impact of antiparkinsonian drugs on the evolution of oculomotricity assessment by video-oculography. - the value of oculomotricity assessment by video-oculography as an evolutionary marker of the disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04731246
Study type Interventional
Source Association de Recherche Bibliographique pour les Neurosciences
Contact Solange HESSE
Phone +377 99995599
Email solange.hesse@chpg.mc
Status Recruiting
Phase N/A
Start date July 7, 2021
Completion date January 2032

See also
  Status Clinical Trial Phase
Completed NCT00244387 - Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa Phase 3
Enrolling by invitation NCT05919160 - A High-density Microelectrode for Human Neuronal Recordings N/A
Completed NCT05575479 - PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables